TeleQuit Smoking Cessation Program

NCT00123682 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3120

Last updated 2015-03-17

Study results available
· View outcomes & findings →

Summary

TeleQuit is a group randomized trial testing whether a telephone care coordination program increases the rate of smoking cessation treatment for VA patients at study sites. We are testing whether proactive care coordination (counselor initiates the call to the patient) is more effective than reactive coordination (coordinator waits for the patient to call); and whether multi-session counseling is more effective than brief primary care-based counseling plus self-help materials. We randomly assigned study sites to either quitline counseling or brief counseling only. All patients receive brief smoking cessation counseling from their primary care physician, smoking cessation medications (once they are in contact with the VA care coordinator), and a follow-up call at 6 months. Care coordination will be provided by VA clinical staff. Intensive counseling is provided by the California Smokers' Helpline.

Conditions

  • Smoking

Interventions

PROCEDURE

Proactive outreach to counseling

Project staff reach out to engage referred smoker into telephone counseling

PROCEDURE

Reactive outreach to counseling

Project staff send a letter to referred smoker, asking them to call to engage in telephone counseling

PROCEDURE

Intensive counseling

Multi-session telephone counseling, delivered by California Smokers' Helpline

PROCEDURE

Self-help

Project staff send out self-help materials for smoking cessation

Sponsors & Collaborators

Principal Investigators

  • Scott E Sherman, MD MPH · New York, NY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2009-03-31
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00123682 on ClinicalTrials.gov